Kawasaki Related Coronary Artery Disease Refractory to Angioplasty: The Role of Intravascular Shockwave Lithotripsy

Teodora Donisan1, Amy Mertens2, Sayed Luay3

  • 1Department of Internal Medicine, Beaumont Hospital, Royal Oak, Royal Oak, USA.

Cureus
|December 2, 2021
PubMed

Insights

Intravascular lithotripsy successfully treated severe coronary artery calcifications in a Kawasaki disease patient with aneurysms. This offers a new option for complex coronary interventions in these high-risk patients.

Area of Science:

  • Cardiology
  • Pediatric Rheumatology
  • Interventional Cardiology

Background:

  • Kawasaki disease is a leading cause of acquired heart disease in children, often leading to coronary artery aneurysms (CAAs).
  • CAAs in Kawasaki disease survivors pose a significant risk for cardiovascular complications and necessitate complex management strategies.
  • Heavily calcified coronary lesions present a therapeutic challenge, particularly in patients with a history of Kawasaki disease.

Observation:

  • A 27-year-old patient with a history of Kawasaki disease at age two presented with severe, calcified coronary artery stenosis and CAAs.
  • Conventional interventional techniques including cutting balloons, orbital atherectomy, and rotational atherectomy were ineffective in treating the calcified stenosis.
  • The patient had undergone appropriate treatment for Kawasaki disease in childhood.

Findings:

  • Intravascular lithotripsy (IVL) was utilized to treat the heavily calcified coronary stenosis, achieving successful lesion preparation.
  • Following IVL, the patient was treated with a drug-eluting stent and a covered stent to exclude the coronary artery aneurysm.
  • A good final angiographic and procedural result was achieved after the combined intervention.

Implications:

  • Intravascular lithotripsy represents a promising therapeutic option for managing severely calcified coronary lesions in patients with Kawasaki disease-associated CAAs.
  • This case highlights the potential of IVL to overcome limitations of traditional atherectomy devices in complex coronary anatomies.
  • Successful management with IVL and stenting may improve long-term cardiovascular outcomes for patients with Kawasaki disease-related coronary complications.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
63
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
48
Urinary Tract Calculi VI: Surgical Management01:25

Urinary Tract Calculi VI: Surgical Management

Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
70
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
113
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
52
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
758